EUVIMEDEUVIMED entdecken
Crossref

Engineered Microglial Exosome–Liposome Hybrid Nanovesicles for Synergistic Therapy of Hypoxic‐Ischemic Encephalopathy by Dual‐Targeting Ferroptosis and Neuroinflammation

Chanyue Wang, Kangqian Tian, Changfeng Jia, Liguo Song, Caifan Wang, Weipeng Gao, Zhaojuan Wang, Jiacan Xu, Yuchen Li, Yalin Li, Qian Liu iD

Advanced Healthcare Materials · 2026-05 · 15 (20)

DOI: 10.1002/adhm.71060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.03.2026. Verfasst von Chanyue Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Microglia, Ferroptosis, Hypoxia-Ischemia, Brain, Liposomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxic–ischemic encephalopathy (HIE) is a major cause of neurological injury in neonates, with pathological cascades such as neuroinflammation and ferroptosis driving disease progression. Current therapeutic strategies for HIE are largely limited to supportive care and therapeutic hypothermia, which fail to effectively target these mechanisms. To address this challenge, we developed a microglia‐derived exosome–liposome hybrid membrane systems (HMS) (R+si@LPs‐TK/TAT+Exo, abbreviated as Rs@LP‐T/T‐E) for the co‐delivery of resveratrol (RES) and acyl‐CoA synthetase long‐chain family member 4 (ACSL4) siRNA. The nanosystem exhibited favorable stability, reactive oxygen species (ROS)‐responsive drug release, and efficient blood–brain barrier (BBB) penetration, enabling targeted accumulation within ischemic brain regions. In experimental models, Rs@LP‐T/T‐E significantly attenuated neuroinflammation and ferroptosis, promoted microglial polarization toward the anti‐inflammatory M2 microglial phenotype, and restored mitochondrial function, thereby reducing cerebral infarct volume and improving cerebral perfusion. In conclusion, this study presents an efficient, targeted, and biocompatible nanodelivery strategy that holds strong translational potential for HIE therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaFerroptosisHypoxia-Ischemia, BrainLiposomesExosomesNeuroinflammatory DiseasesAnimalsResveratrolRNA, Small InterferingCoenzyme A LigasesMiceReactive Oxygen SpeciesBlood-Brain Barrier

Stichwörter der Autor:innen

acyl‐CoA synthetase long‐chain family member 4 (ACSL4) siRNAhypoxic‐ischemic encephalopathy (HIE)microgliananovesiclesresveratrol (RES)

Substanzen

LiposomesResveratrolRNA, Small InterferingCoenzyme A LigasesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Neurosurgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, China.
  • Department of Basic Medicine, School of Basic Medical Sciences, Shandong Medical College, Jinan, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.

ORCID-Profile: Qian Liu

Förderung

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Wang, C., Tian, K., Jia, C., Song, L., Wang, C., Gao, W., Wang, Z., Xu, J., Li, Y., Li, Y., & Liu, Q. (2026). Engineered Microglial Exosome–Liposome Hybrid Nanovesicles for Synergistic Therapy of Hypoxic‐Ischemic Encephalopathy by Dual‐Targeting Ferroptosis and Neuroinflammation. Advanced Healthcare Materials, 15(20). https://doi.org/10.1002/adhm.71060

Vancouver

Wang C, Tian K, Jia C, Song L, Wang C, Gao W, et al. Engineered Microglial Exosome–Liposome Hybrid Nanovesicles for Synergistic Therapy of Hypoxic‐Ischemic Encephalopathy by Dual‐Targeting Ferroptosis and Neuroinflammation. Advanced Healthcare Materials. 2026;15(20). doi:10.1002/adhm.71060

BibTeX
@article{Wang2026,
  author = {Wang, Chanyue and Tian, Kangqian and Jia, Changfeng and Song, Liguo and Wang, Caifan and Gao, Weipeng and Wang, Zhaojuan and Xu, Jiacan and Li, Yuchen and Li, Yalin and Liu, Qian},
  title = {Engineered Microglial Exosome–Liposome Hybrid Nanovesicles for Synergistic Therapy of Hypoxic‐Ischemic Encephalopathy by Dual‐Targeting Ferroptosis and Neuroinflammation},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {20},
  doi = {10.1002/adhm.71060}
}
Kostenlos starten →